Differential sensitivities of trastuzumab (Herceptin®)-resistant human breast cancer cells to phosphoinositide-3 kinase (PI-3K) and epidermal growth factor receptor (EGFR) kinase inhibitors - Concepedia

Concepedia

Publication | Closed Access

Differential sensitivities of trastuzumab (Herceptin®)-resistant human breast cancer cells to phosphoinositide-3 kinase (PI-3K) and epidermal growth factor receptor (EGFR) kinase inhibitors

87

Citations

36

References

2005

Year

Carmel T. Chan, Marianne Z. Metz, Susan E. Kane

Breast Cancer Research and Treatment

Breast OncologyPhosphoinositide-3 KinaseMedicineReceptor Tyrosine KinaseKinase InhibitorsDifferential SensitivitiesBreast CancerAnti-cancer AgentPharmacologyCell BiologyCell SignalingTumor BiologyEndocrine-related Cancer

References

	Year	Citations

Page 1